News Focus
News Focus
icon url

Superfly15

02/24/12 12:27 AM

#137755 RE: biomaven0 #137753

VVUS - I doubt the approval is baked in, there is still significant risk of the FDA shutting them down. Would not surprise me if it doubles again on approval.

That said, I was one of those who happily sold for a double last night, and am hoping for a pullback of a few points before I consider taking the risk again.
icon url

DewDiligence

02/24/12 1:39 AM

#137760 RE: biomaven0 #137753

I lose all respect for an analyst when they make statements like…

Matt Herper is a reporter, not an analyst.
icon url

turtlepower

02/24/12 3:12 AM

#137764 RE: biomaven0 #137753

VVUS - Regarding valuation, what kind of REMS will be used do you think? The FDA REMS seemed much less restrictive than VVUS and it looks like even women of childbearing potential could have access to it. Isn't access to women of childbearing potential the most important aspect of the label and the one most likely to determine whether qnexa will be blockbuster?
icon url

rurik

02/24/12 8:03 AM

#137770 RE: biomaven0 #137753

Agree on this point